Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.
Wiersinga WM, Poppe KG, Effraimidis G.
Lancet Diabetes Endocrinol. 2023 Apr;11(4):282-298. doi: 10.1016/S2213-8587(23)00005-0. Epub 2023 Feb 24.
Hyperthyroidism.
Chaker L, Cooper DS, Walsh JP, Peeters RP.
Lancet. 2024 Feb 24;403(10428):768-780. doi: 10.1016/S0140-6736(23)02016-0. Epub 2024 Jan 23.
[Nodular toxic goiter in children: clinical features, morphological variants].
Ivannikova TE, Bezlepkina OB, Abdulhabirova FM, Abrosimov AU, Degtyarev MV, Zubkova NA.
Probl Endokrinol (Mosk). 2021 Apr 8;67(2):102-110. doi: 10.14341/probl12738.
Toxic nodular goiter and thyroid cancer: Is hyperthyroidism protective against thyroid cancer?
Tam AA, Ozdemir D, Alkan A, Yazicioglu O, Yildirim N, Kilicyazgan A, Ersoy R, Cakir B.
Surgery. 2019 Sep;166(3):356-361. doi: 10.1016/j.surg.2019.03.012. Epub 2019 May 16.
Etiopathology of feline toxic nodular goiter.
Gerber H, Peter H, Ferguson DC, Peterson ME.
Vet Clin North Am Small Anim Pract. 1994 May;24(3):541-65. doi: 10.1016/s0195-5616(94)50058-5.
Therapeutic options in the management of toxic and nontoxic nodular goiter.
Freitas JE.
Semin Nucl Med. 2000 Apr;30(2):88-97. doi: 10.1053/nm.2000.4597.
Toxic nodular goiter. Toxic adenoma and toxic multinodular goiter.
Siegel RD, Lee SL.
Endocrinol Metab Clin North Am. 1998 Mar;27(1):151-68. doi: 10.1016/s0889-8529(05)70304-2.
Animal models of disease: feline hyperthyroidism: an animal model for toxic nodular goiter.
Peterson ME.
J Endocrinol. 2014 Nov;223(2):T97-114. doi: 10.1530/JOE-14-0461.
[Toxic nodular goiter].
Sarr A, Ndour MM, Diop SN, Ka CM, Dieng P, Diedhiou D, Sidibé EH, Sow AM.
Dakar Med. 2007;52(2):135-40.
Toxic nodular goiter and cancer: a compelling case for thyroidectomy.
Smith JJ, Chen X, Schneider DF, Nookala R, Broome JT, Sippel RS, Chen H, Solorzano CC.
Ann Surg Oncol. 2013 Apr;20(4):1336-40. doi: 10.1245/s10434-012-2725-4. Epub 2012 Oct 30.
